BIOREM Inc. BIRMF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 165.76% | 466.80% | 1,591.64% | -47.71% | 118.64% |
| Total Depreciation and Amortization | -8.75% | -29.14% | -31.90% | -28.95% | 44.24% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -112.75% | 48.51% | 82.84% | -50.74% | 77.32% |
| Change in Net Operating Assets | -93.38% | -135.83% | 136.00% | -540.87% | 0.16% |
| Cash from Operations | -111.11% | -125.16% | 300.73% | -71.15% | 30.36% |
| Capital Expenditure | 92.17% | -212.48% | -445.95% | -- | -6,566.67% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 92.17% | -212.48% | -445.95% | -- | -6,566.67% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.21% | 10.00% | -12.04% | 28.56% | -10.06% |
| Issuance of Common Stock | -- | -- | -90.12% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 14.20% | 5.85% | -576.92% | -19.88% | -8.77% |
| Foreign Exchange rate Adjustments | 215.81% | 793.33% | 83.27% | -92.32% | -332.46% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -44.05% | -136.12% | 253.64% | -79.59% | 3.73% |